Skip to content. | Skip to navigation


Personal tools

Brad Nelson, PhD

Peer-Reviewed Papers

2014

  • Webb, J.R., Milne, K., Nelson, B.H. 2013. Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8+ tumor-infiltrating lymphocytes in ovarian cancer. Oncoimmunology, in press.

  • Brown, S.D., Warren, R.L., Gibb, E.A., Martin, S.D., Spinelli, J.J., Nelson, B.H., Holt, R.A. 2014. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Research. In press.
  • Wick DA, Webb JR, Nielsen JS, Martin SD, Kroeger DR, Milne K, Castellarin M,Twumasi-Boateng K, Watson PH, Holt RA, Nelson BH. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014 Mar 1;20(5):1125-34. doi: 10.1158/1078-0432.CCR-13-2147.Epub 2013 Dec 9. [PubMed - 24323902]


2013

  • Webb JR, Milne K, Watson PH, Deleeuw RJ, Nelson BH, Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res. 2013 Nov 4. [Epub ahead of print] PMID 24190978
  • Sio A. B, Chehal, M.K. B, Tsai K., Fan, X., Roberts, M.E., Nelson, B.H., Grembecka, J., Cierpicki, T., Krebs D.L., and Harder, K.W. 2013. Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and Hox gene expression in hematopoietic cells. Cancer Res. Oct 1;73(19):5892-904. PMID: 23913828.

  •  West, N.R., Kost, S.E., Martin, S.D., Milne, K., deLeeuw, R.J., Nelson, B.H., Watson, P.H. 2013. Tumor-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor negative breast cancer. British Journal of Cancer, 2013 Jan 15;108(1):155-62. doi: 10.1038/bjc.2012.524. Epub 2012 Nov 20.[PubMed - 23169287]
  • Castellarin, M., Milne, K., Zeng, T., Tse, K., Mayo, M., Zhao, Y., Webb, J.R., Watson, P.H., Nelson, B.H., Holt, R.A. 2013. Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J. Pathol. Mar. 229(4):515-24. . [PubMed - 22996961]

 

2012

  • Nelson, B.H. 2012. Lead editorial: Killer T cells to the rescue in ovarian cancer. Gynecol Oncol. Feb; 124(2):178-9. [PubMed - 22264602] 
  • Nielsen, J.S. and Nelson, B.H. 2012. Tumor-infiltrating B cells and T cells: working together to promote patient survival. Oncoimmunology. 2012 Dec 1;1(9):1623-1625. [PubMed - 23264915]

  • DeLeeuw, R.J., Kost, S.E., Kakal, J., and Nelson, B.H. 2012. The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: A critical review of the literature. Clin Cancer Res. Jun 1; 18(11):3022-9. [PubMed - 22510350] 
  • Nielsen, J.S., Sahota, R.A., Milne, K., Kost, S.E., Nesslinger, N.J., Watson, P.H., Nelson, B.H. 2012. CD20+ tumour-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res. Jun 15. 18(12):3281-92. [PubMed - 22553348] 
  • Milne, K., Alexander, C., Webb, J.R., Sun, W., Dillon K., Kalloger, S.E., Gilks, C.B., Clarke, B., Kobel, M., and Nelson, B.H. 2012. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J. Transl. Med. Feb 27; 10:33.[PubMed - 22369276]  
  • McAlpine, J.N., Porter, H., Kobel, M., Nelson, B.H., Prentice, L.,  Kalloger, S.E., Senz, J., Milne, K., Ding, J., Shah S.P., Huntsman, D.G., and Gilks, C.B. 2012. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod. Pathology. May;25(5):740-50. Epub 2012 Jan 27. [PubMed - 22282309] 


2011

  • Fox B.A., Schendel, D.J., Butterfield, L.H., Aamdal, S., Allison, J.P., Ascierto, P.A., Atkins, M.B., Bartunkova, J., Bergmann, L. Berinstein, N.L., Bramson, J.L., Britten, C.M., Carson, W.E., Characiejus, D., Choudhury, A.R., Coukos, G., Dranoff, G., Finke, J.H., Gollob, J.A., Gouttefangeas, C., Grizzi, F., Guida, M., Hakansson, L., Hege, K., Hodi, F.S., Hoos, A., Hwu, P., Kaufman, H.L., Kawakami, K., Kawakami, Y., Khleif, S.N., Kiessling, R., Jaffee, E.M. Janetzki, S., June, C.H., Lapointe, R., Levitsky, H.I., Maio, M., Marschner, J.-P., Murphy, W.J., Maccalli, C., Masucci, G., Nelson, B., Nicolini, A., Odunsi, K., Ohashi, P.S., O'Donnell-Tormey, J., Old, L.J., Ottensmeier, C., Papamichail, M., Parmiani, G., Pawelec, G., Proietti, E., Qin, S., Ribas, A., Ridolfi, R., Ritter, G., Rivoltini, L., Romero, P., Sharma, P., Seliger, B., Shiku, H., Song, W., Straten, P.T., Tahara, H., van Der Burg, S.H., von Hoegen, P., Wang, E., Welters, M.J.P., Wolchok, J.D., Zwierzina, H., Marincola, F.M., Gajewski, T.F., Wigginston, J.M., and Disis, M.L. 2011. Defining the Critical Hurdles in Cancer Immunotherapy. J Transl Med. Dec 14;9(1):214. [PubMed - 22168571]  
  •  West, N.R., Milne, K., Truong, P.T., MacPherson, N., Nelson, B.H., Watson, P.H. 2011. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Res. Dec 8;13(6):R126. [PubMed - 22151962] 
  •  Pere, H. Montier, Y., Bayry, J., Quintin-Colonna, F., Merillon, N., Dransart, E., Badoual, C., Gey, A., Ravel, P., Marcheteau, E., Batteux, F., Sandoval, F., Adotevi, O., Chiu, C., Garcia, S., Tanchot, C., Lone, Y-C., Ferreira, L.C.S., Nelson, B.H., Hanahan, D., Fridman, W.H., Johannes, L., Tartour, E. 2011.  A CCR4 antagonist combined with vaccines induces antigen-specific CD8+T cells and tumor immunity against self antigens. Blood. Nov 3; 118(18):4853-62. Epub 2011 Sep 9.  [PubMed - 21908423]
  • Salzman J, Marinelli RJ, Wang PL, Green AE, Nielsen JS, Nelson BH, Drescher CW, Brown PO. ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma. PLoS Biol. 2011 Sep;9(9):e1001156. Epub 2011 Sep 20. [PubMed - 21949640]
  • Ho V, Leung K, Hsu A., Luk B, June L, Shen K, Minchinton A, Bally M, Nelson BH, Sly LM, Krystal G. 2011. A low carbohydrate, high protein diet slows and may prevent cancer. Cancer Research. Jul 1 71(13):4484-93. Epub 2011 Jun 14. [PubMed - 21673053]
  • Nelson, B.H. and Webb, J.R. Tumor-specific mutations as targets for cancer immunotherapy. Experimental and Applied Immunotherapy 2011. Chapter 7 (pgs. 151-172), Springer. ISBN: 978-1-60761-979-6.


2010

  • Tran E, Nielsen JS, Wick DA, Ng AV, Johnson LD, Nesslinger NJ, McMurtrie E, Webb JR, Nelson BH.  Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS ONE 5(12): e15625 (Dec 2010). [PubMed - 21203522]

  • Wick DA, Martin SD, Nelson BH, Webb JR. Profound CD8(+) T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C). Vaccine. 2010 Nov 27. [Epub ahead of print] [PubMed - 21115055].

  • Nesslinger NJ, Ng A, Tsang KY, Ferrara T, Schlom J, Gulley JL, Nelson BH. A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients. Clin Cancer Res. 2010 Aug 1;16(15):4046-56. [PubMed - 20562209]

  • Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol. 2010 Nov 1;185(9):4977-82. [PubMed - 20962266].
  • Chen R, Pan S, Duan X, Nelson BH, Sahota RA, de Rham S, Kozarek RA, McIntosh M, Brentnall TA. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer. 2010 Jun 15;9:149. [PubMed - 20550709]
  • Nielsen JS, Wick DA, Tran E, Nelson BH, Webb JR. An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies. J Immunol Methods. 2010 Jul 15. [Epub ahead of print] [PubMed - 20637775]

  • Webb JR, Wick DA, Nielsen JS, Tran E, Milne K, McMurtrue E, Nelson BH.  Profound elevation of CD8(+) T cells expressing the intraepithelial lymphocyte marker CD103 (alpha(E)/beta(7) Integrin) in high-grade serous ovarian cancer. Gynecol Oncol. 2010 Jun 9 [Epub ahead of print] [PubMed - 20541243] Related citations

  • Martin, M.L., Wall, E.M., Sandwith E., Girardin, A., Milne, K., Watson, P.H., Nelson, B.H. 2010. Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model. Breast Cancer Res  Treat.  Sep 30 [Epub ahead of print]. [PubMed - 19789976]


2009

  • Milne, K., Köbel, M., Kalloger, S.E., Barnes, R.O., Gilks, B., Watson, P.H. , Nelson, B.H. 2009. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One. 2009 Jul 29; 4(7):e6412. [PubMed - 19641607]
  • Hahn, S., Nesslinger, N.J., Drapala, R., Bowden, M., Rennie, P., Pai, H.H., Ludgate, C., Nelson, B.H. 2009. Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen-dependent murine tumor model. Int J Cancer. 2009 Dec 15; 125(12):2871-8. [PubMed - 19554630]
  • Freeman, J.D., Warren, R.L., Webb, J.R., Nelson, B.H., and Holt, R.A. 2009. Profiling the T-cell Receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 2009 Oct; 19(10):1817-24. [PubMed - 19541912]
  • Yang, T., Martin, M.L., Nielsen, J.S., Milne, K., Wall, E.M., Lin, W., Watson, P.H., Nelson, B.H. 2009. Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the cbl-b gene. Cancer Immunol Immunother. 2009 Nov; 58(11):1865-75. [PubMed - 19350239]
  • Warren, R.L., Nelson, B.H., Holt, R.A. 2009. Profiling model T cell metagenomes with short reads. Bioinformatics. Feb 15; 25(4):458-464. [PubMed - 19136549]
  • Nelson, B.H. 2009. Lead editorial: IDO and outcomes in ovarian cancer. Gynecol Oncol. 2009 Nov; 115(2):179-80


2008

  • Milne, K., Barnes, R.O., Girardin, A., Mawer, M.A., Nesslinger, N.J., Ng, A., Nielsen, J.S., Sahota, R., Tran, E., Webb, J.R., Wong, M.Q., Wick., D.A., Wray, A., McMurtrie, E., Köbel, M., Kalloger, S.E., Gilks, B., Watson, P.H. , Nelson, B.H. 2008. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer. PLoS One. Oct 8; 3(10):e3409.  [PubMed - 18923710]
  • Palmer,C., Duan, X., Hawley, S., Scholler,N., Thorpe, J.D., Sahota, R., Wong, M., Wray, A., Drescher, C., McIntosh, M., Brown,P.,  Nelson, B.H., Urban, N. 2008. Systematic evaluation of candidate blood markers for detecting ovarian cancer. PLoS One. Jul 9; 3(7):e2633. [PubMed - 18612378]
  • Nesslinger, N.J., Pai, H.H., Ludgate, C.M., Nelson, B.H. 2008.  Exploring the effects of standard treatments on the immune response to prostate cancer. Methods of cancer diagnosis, therapy, and prognosis. Springer, Vol. 2.

  • Nelson, B.H.  2008. The impact of T cell immunity on ovarian cancer outcomes.  Immunological Reviews 2008. Vol. 222: 101-116. [PubMed - 18363996]
  • McIntosh, M., Anderson, G., Drescher, C., Hanash, S., Urban, N., Brown, P., Gambhir, S.S., Coukos, G., Laird, P.W., Nelson, B., Palmer, C. 2008. Letter to the Editor: Ovarian cancer early detection claims are biased. Clinical Cancer Research. 14(22):7574. [PubMed - 18948385]


2007

  • Thorpe, J.D., Duan, X., Forrest, R., Lowe, K., Brown, L., Segal, E., Nelson, B.H., Anderson, G.L., McIntosh, M., Urban, N. 2007. Effects of blood collection conditions on ovarian cancer serum markers. PLoS One. Dec 5; 2(12):e1281.  [PubMed - 18060075]
  • Yang, T., Wall, E.M., Milne, K., Theiss P., Watson, P.H., Nelson, B.H. 2007. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism. Clin Cancer Res. 13(23):7172-80. [PubMed - 18056198]
  • Lockyer, H., Tran, E., Nelson, B.H. 2007. Stat5 is essential for Akt/S6 kinase activity during IL-2 induced lymphocyte proliferation. J Immunol.  Oct 15;179(8):5301-8. [PubMed - 17911616]
  • Wall, E.M., Milne, K., Martin, M.L., Watson, P.H., Theiss, P., Nelson, B.H. 2007. Spontaneous mammary tumors expressing an epitope-tagged HER2/neu oncogene show a range of therapeutic responses to adoptively transferred CD4+ and CD8+ T cells. Cancer Res. Jul 1; 67(13): 6442-6450. [PubMed - 17616705]
  • Nesslinger, N.J., Sahota, R.A., Stone, B., Johnson, K., Chima, N., King, C., Rasmussen, D., Bishop, D., Rennie, P.S., Gleave, M., Blood, P., Pai, H., Ludgate, C., Nelson, B.H. 2007. Standard treatments induce antigen-specific immune responses in prostate cancer. Clin Cancer Res. Mar 1; 13(5):1493-502. [PubMed - 17332294]


2006

  • Erkanli, A., Taylor, D.D., Dean, D., Eksir, F., Egger, D., Geyer, J., Nelson, B.H., Stone, B., Fritsche, H.A. and Roden, R.B.S. 2006. Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection. Cancer Res. Feb 1; 66(3):1792-8. [PubMed - 16452240]


2005

  • Farris, S.D., Rubio, E.D., Moon, J.J., Gombert, W.M., Nelson, B.H., Krumm, A. 2005. Transcription-induced chromatin remodeling at the C-Myc gene involves a local exchange of histone H2A.Z. J Biol Chem. 280(26):25298-303. [PubMed - 15878876]


2004

  • de Mattos, S.F., Essafi, A., Soeiro I., Pietersen, A.M., Birkenkamp, K.U., Edwards, C.S., Martino, A., Nelson, B.H., Francis, J.M., Jones, M.C., Brosens, J.J., Coffer, P.J., and Lam, E.W.-F. 2004. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol Cell Biol. , Nov; 24(22):10058-71. [PubMed - 15509806]
  • Teague, R.M., Tempero, R.M., Thomas, S., Kaja, M.-K. and Nelson, B.H. 2004. Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor β chain expression or STAT5 activation. J Immunol. Sep 1;173(5):3131-3139. [PubMed - 15322173]
  • Moon, J.J., Rubio, E.D., Marino, A., Krumm, A., Nelson, B.H.  2004. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor. J Biol Chem. Feb 13;279(7):5520-7. [PubMed - 14660677]
  • Nelson, B.H.  2004. Interleukin-2, regulatory T cells and tolerance. J Immunol.172:3983-8. [PubMed - 15034008]


2003

  • Nelson, B.H., Martyak, T.P., Thompson, L.J., Moon, J.J., Wang, T. 2003. Uncoupling of pro-mitogenic and anti-apoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol.170:5563-70
  • Stone, B., Schummer, M., Paley, P.J., Thompson, L., Stewart, J., Ford, M., Crawford, M., Urban, N., O’Briant, K., Nelson, B.H. 2003. Serological analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. International Journal of Cancer 104:73-84


2002

  • Cheng, L.E., Öhlén, C., Nelson, B.H. and Greenberg, P.D. 2002. Enhanced signaling through the IL-2 receptor in CD8 + T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8 + T cells rather than promotion of cell death. Proceedings of the National Academy of Sciences 99:3001-3006 [PubMed - 115867736]
  • Nelson, B.H. 2002. The interleukin-2 signaling and the maintenance of self-tolerance. Current Directions in Autoimmunity, A.N. Theofilopoulos (series ed), A. Altman (ed). Basel, Karger. 5:92-112 


2001

  • Moon, J.J. and Nelson, B.H. 2001. PI3 kinase potentiates but does not trigger proliferative signaling by the interleukin-2 receptor in T cells. J Immunol.167:2714-2723  [PubMed - 11509615] 
  • Stone, B., Schummer, M., Paley, P.J., Crawford, M., Ford, M., Urban, N., and Nelson, B.H.  2001. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene. 267:173-182  [PubMed - 11313144]


2000

  • Martino, A., Holmes, J.H., Lord, J.D., Moon, J.J., and Nelson, B.H.  2000. Stat5 and Sp1 regulate transcription of the cyclin D2 gene in response to IL-2. J Immunol.166:1723-1729   [PubMed - 11160217]
  • Gu, H., Maeda, H., Moon, J.J., Lord, J.D., Yoakim, M., Nelson, B.H., and Neel, B.G.  2000. A new role for Shc in activation of the PI-3K/Akt pathway. Mol Cell Biol.  20:7109-7120  [PubMed - 10982827]
  • Lord, J.D., McIntosh, B.C., Greenberg, P.D., and Nelson, B.H.  2000.  The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2 and bcl-x genes through the transactivation domain of Stat5. J Immunol.164:2533-2541  [PubMed - 10679091]


1999

  • Evans, L.S., Witte, P.R., Feldhaus, A.L., Nelson, B.H., Riddell, S.R., Greenberg, P.D., Lupton, S.L., and Jones, L.A.  1999. Expression of GM-CSFR/IL-2R chimeric receptors in human CTL  clones results in GM‑CSF dependent growth.  Human Gene Therapy 10:1941-1951  [PubMed - 10466628]
  • Hunt, A.E., Lali, F.V., Lord, J.D., Nelson, B.H., Tracey, K.J., and Foxwell, B.M.J. 1999. Role of Interleukin (IL)-2 Receptor beta-Chain Subdomains and Shc in p38 Mitogen-activated Protein (MAP) Kinase and p54 MAP Kinase (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Activation. Il-2-driven proliferation is independent of p38 and p54 map kinase activation. J Biol Chem. 274:7591-7597 [PubMed - 10066828]


1998

  • Lord, J.D., McIntosh, B.C., Greenberg, P.D., and Nelson, B.H. 1998. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.  J Immunol.161:4627-4633
  • Ferrag, F., Pezet, A., Chiarenza, A., Buteau, H., Nelson, B.H., Goffin, V., and Kelly, P.A.  1998. Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathways.  FEBS Letters 421:32-36  [PubMed - 9462834] 
  • Greenberg, P.D., Finch, R.J., Gavin, M.A., Kalos, M., Lewinsohn, D.A., Lonergan, M.A., Lord, J.D., Nelson, B.H., Ohlen, C., Sing, A.P., Waren, E.H., Yee, C., and Riddell, S.R. 1998. Genetic modification of T cell clones for therapy of human viral and malignant diseases.  Cancer J Sci Am. 4: -S105. [PubMed - 9679278]
  • Nelson, B.H. and Willerford, D.M. 1998. The Biology of the Interleukin-2 Receptor.  Adv Immunol. 70:1-81. [PubMed - 9755337]


1997

  • Soto, J.G., Nelson, B.H., and Weisblat, D.A. 1997. A leech homolog of twist: evidence for its inheritance as a maternal mRNA.  Gene 199:31-37   [PubMed - 9358036]   
  • Reichel, M., Nelson, B.H., Greenberg, P.D., and Rothman P.B. 1997. The interleukin‑4 receptor a chain cytoplasmic domain is sufficient for activation of JAK‑1 and Stat6 and induction of IL‑4‑specific gene expression. J Immunol.158:5860-5867
  • Iversen, P.O., Hercus, T.R., Zacharakis, B., Woodcock, J.M., Stomski, F.C., Kumar, S., Nelson, B.H., Miyajima, A., Lopez, A.F. 1997. The apoptosis-inducing granulocyte-macrophage colony-stimulating factor (GM-CSF) analog E21R functions through specific regions of the heterodimeric GM-CSF receptor and requires interleukin-1b-converting enzyme-like proteases. Journal of  Biological Chemistry 272:9877-9883
  • Nelson, B.H., McIntosh, B.C., Rosencrans, L.L., and Greenberg, P.D. 1997. Requirement for an initial signal from the membrane‑proximal region of the interleukin‑2 receptor gc chain for Janus kinase activation leading to T‑cell proliferation. Proceedings of the National Academy of Sciences 94:1878-1883
  • Nelson, B.H. and Greenberg, P.D. 1997. The Interleukin‑2 Receptor. In: Encyclopedia of Immunology 2nd Edition, Eds. P.J. Delves and I. Roitt. Academic Press


1996

  • Nelson, B.H., Lord, J.D., and Greenberg, P.D. 1996. A membrane‑proximal region of the interleukin‑2 receptor gc chain sufficient for Jak kinase activation and induction of proliferation in T cells. Mol Cell Biol.  16:309-317


1994

  • Greenberg, P.D., Nelson, B., Gilbert, M., Sing, A., Yee, C., Jensen, M. and S.R. Riddell. 1994. Genetic modification of T cell clones to improve safety and efficacy of adoptive T cell therapy. London: CIBA Found Symp #187, pp. 443‑54.  [PubMed - 7796672] 
  • Nelson, B.H., Lord, J.D. and P.D. Greenberg. 1994. Cytoplasmic domains of the interleukin‑2 receptor b and g chains mediate the signal for T‑cell proliferation. Nature 369:333-336


1993

  • Greenberg, P.D., Gilbert, M., Nelson, B., Nagoya, S., Yee, C., Finch, L., Walter, B., and Riddell, S.R. 1993. Adoptive therapy of human viral disease with virus‑specific CD8+ cytolytic T cell clones. In: Cytokine Induced Tumor Immunogenicity, Eds. G. Forni, R. Foa, A. Santoni and L. Frati. Academic Press, pp. 212-228.


1992

  • Nelson, B.H. and D.A. Weisblat. 1992. Cytoplasmic and cortical determinants interact to specify ectodermal and mesodermal precursors in the leech embryo. Development 115:103-115


1991

  • Nelson, B.H. and D.A. Weisblat. 1991. Conversion of ectoderm to mesoderm by cytoplasmic extrusion in the leech embryo. Science 253:435-438
  • Hasan, S.J., Nelson, B.H., Valenzuela, I., Keirstead, H.S., Shull, S.E., Ethell, D.W. and J.D. Steeves. 1991. Functional repair of transected spinal cord in embryonic chick. Restorative Neurology and Neuroscience 2:137-154